Category: Press

Barron’s: Bill Smead on Amgen

This Biotech Stock Is a Remedy for Tougher Times By Al Root For more information go to www.barrons.com. Stocks mentioned: AMGN The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no

⟶ Keep Reading

Citywire Americas: Bill Smead Discusses Tech Titans

US Watch: PMs tackle tech titans’ mounting regulatory pressure Citywire Americas by Atholl Simpson For more information go to www.citywireamericas.com.   The information contained in this tv appearance represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is

⟶ Keep Reading

Bloomberg Markets: Tony Scherrer on Banks

‘Amazing Numbers’ at Canadian Banks Are No Match for U.S. Tax Cuts By Doug Alexander For more information go to www.bloomberg.com. The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no

⟶ Keep Reading

WSJ: Tony Scherrer on Brick-and-Mortar Retail

Strong Consumption Is Breathing New Life Into Retail Stocks By Ben Eisen For more information go to www.wsj.com. Stocks mentioned: TGT The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no

⟶ Keep Reading

Barron’s: Bill Smead on Target and Demographics

Target’s Strong Earnings Lift Stock to Record High By Teresa Rivas For more information go to www.barrons.com. Stocks mentioned: TGT The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee

⟶ Keep Reading

Bloomberg: Bill Smead on the Health Care Sector

Investors Pile Into Health to Shield Holdings From Trade War By Tatiana Darie For more information go to www.bloomberg.com. The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of

⟶ Keep Reading

Barron’s: Tony Scherrer, CFA on Home Depot

The Market Can’t Decide If Home Depot’s Earnings Are Worth Celebrating By Teresa Rivas For more information go to www.barrons.com. Stocks mentioned: HD The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance

⟶ Keep Reading

Barron’s: Bill Smead on Anemic Recovery

Morning Movers: Apple Lifts Tech While Trade Hits the Dow By Teresa Rivas For more information go to www.barrons.com. The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of

⟶ Keep Reading
Scroll to Top